GlobeNewswire Inc.··NaNkarta to Present at Two Major Healthcare Investment Conferences in March
Nkarta to present at two major healthcare investor conferences in March 2026, showcasing updates on its engineered NK cell therapy pipeline for autoimmune diseases.
NKTXNK cell therapiesautoimmune diseases